It is specifically beneficial in addressing alcoholic fatty liver, which results from excessive alcohol consumption, liver fibrosis/cirrhosis caused by alcohol abuse, and hepatitis, which is the inflammation of the liver
It is not FDA or Health Canada approved for any use
Furthermore, treatment with GLP1/E, GLP1/GIP, or metformin did not modify ovarian and uterus weights, or serum LH levels
Other GLP-1 options include liraglutide (Saxenda) and oral semaglutide (Rybelsus), though both are generally considered less effective for weight loss than injectable semaglutide at higher doses
GHK-CU is a generalist
Dosing BPC-157 Oral Capsules Preclinical experiments reveal that BPC-157 may also be administered orally, such as in the form of BPC-157 capsules , especially during research related to gut healing